---
schema_version: "secwatch.filing_event.v1"
accession: "0001285550-23-000019"
form_type: "8-K"
ticker: "CLPT"
cik: "0001285550"
company_name: "ClearPoint Neuro, Inc."
filed_at: "2023-03-01T23:59:59+00:00"
generated_at: "2026-06-18T17:12:05.208524+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# ClearPoint Neuro reports Q4 2022 revenue $5.2M (+21% YoY); full-year revenue $20.6M (+26% YoY)

## Summary
- Q4 2022 revenue $5.2M, up 21% YoY; full-year revenue $20.6M, up 26% YoY (record).
- Biologics & drug delivery revenue $9.1M for 2022, up 34% YoY; over 50 partners.
- Gross margin 66% for 2022 vs 68% in 2021; Q4 gross margin 64% vs 77%.
- Cash & short-term investments $37.5M at Dec 31, 2022, down from $54.1M.
- Reiterates 2023 revenue guidance $25-27M, expecting >20% growth.

## SEC filing metadata
- accession: 0001285550-23-000019
- form_type: 8-K
- ticker: CLPT
- cik: 0001285550
- company_name: ClearPoint Neuro, Inc.
- filed_at: 2023-03-01T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1285550/000128555023000019/0001285550-23-000019-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1285550/000128555023000019/clpt-20230301.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001285550-23-000019
- JSON: https://secwatch.observer/filing/0001285550-23-000019.json
- Plain text: https://secwatch.observer/filing/0001285550-23-000019.txt

## Key facts
- Earnings Releases
  ClearPoint Neuro, Inc. reported the year ended December 31, 2022 results: revenue $20.6 million. Guidance reaffirmed.
  - Period: the year ended December 31, 2022
  - Revenue: $20.6 million
  - Guidance: reaffirmed
  - Result: reported results
  source text: Total revenue was $20.6 million and $16.3 million for the years ended December 31, 2022 and 2021, respectively.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1285550/000128555023000019/0001285550-23-000019-index.htm
- Earnings Releases
  ClearPoint Neuro, Inc. reported the three months ended December 31, 2022 results: revenue $5.2 million.
  - Period: the three months ended December 31, 2022
  - Revenue: $5.2 million
  - Result: reported results
  source text: Total revenue was $5.2 million for the three months ended December 31, 2022, and $4.3 million for the three months ended December 31, 2021, which represents an increase of $0.9 million, or 21%.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1285550/000128555023000019/0001285550-23-000019-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.